Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05825079
Other study ID # 22-01427
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 9, 2023
Est. completion date November 1, 2024

Study information

Verified date March 2024
Source NYU Langone Health
Contact Joseph Robin, MD
Phone (205)-908-6889
Email Joseph.robin@nyulangone.org
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this study is to determine if weight-bearing crutch technology that delivers active feedback to patients during their treatment will impact patient compliance with physician instructions.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date November 1, 2024
Est. primary completion date November 1, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Willing and able to participate in study and complete consent - Will undergo treatment of an isolated tibial plateau, pilon, or ankle fracture and placed in a non-weightbearing status with the use of crutches at NYU. - Have access and use of a mobile phone (exclusively iOS and/or Android devices) Exclusion Criteria: - Patients with concomitant TBI - Polytrauma patients - Pathologic fractures - Prisoners

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Weight-Bearing Feedback
Feedback on how much weight patients are exerting on their crutch/injured lower extremity (measured via Smart Crutch Tip) will be delivered to their mobile phones.
Device:
Smart Crutch Tip
The device is attached to the crutch and measures how much weight-bearing load is exerted onto its axis. The device is capable of transmitting this data into the patient and physicians' user interface.

Locations

Country Name City State
United States NYU Langone Health New York New York

Sponsors (2)

Lead Sponsor Collaborator
NYU Langone Health ComeBack Mobility

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Percent (%) Change in Average Weight On Crutch from Week 2 to Week 12 Average weight put on crutch measured using the Smart Crutch Tip. Week 2, Week 12
Secondary Time to Recovery Measured as the duration of time from treatment (operative or non-operative) to recovery. Up to Week 12
Secondary Change in Visual Analogue Scale (VAS) - Pain Score from Baseline to Week 12 Participants rate pain using a VAS ranging from 0 (no hurt) to 10 (unbearable pain). A decrease in scores indicates pain decreased during the observational period. Baseline, Week 12
Secondary Percent (%) of Participants with Injury Complications Up to Week 12
Secondary Percent (%) of Participants who Experience Nonunion/Malunion of Lower Extremity Injury Nonunion/malunion assessed using radiographic imaging. Up to Week 12
See also
  Status Clinical Trial Phase
Terminated NCT00548496 - A Phase IIa Study Of Men And Post-Menopausal Women With A Fractured Distal Radius Phase 2
Completed NCT00907296 - Study of Romosozumab (AMG 785) in Tibial Diaphyseal Fractures Status Post Intramedullary Nailing Phase 2
Completed NCT03286270 - A mRUS Validation Study for Nail-treated Fractures of Long Bones and a TUS Exploratory Study for Nail and Plate-treated Fractures of Long Bones
Not yet recruiting NCT04533984 - Fracture Recovery for Returning to Duty (Teriparatide STRONG) Phase 4
Recruiting NCT03232216 - Vitamin D Supplementation and Tibia Fracture. Does it Improve Healing Rate? N/A
Recruiting NCT04941612 - Use of the Bioabsorbable Activa IM-Nailâ„¢ in Pediatric Diaphyseal Forearm Fractures N/A
Recruiting NCT01070576 - Arginine and Nitric Oxide (NO) Early Prognostic Markers for Non-union Development N/A
Completed NCT01081678 - Study To Assess FRacTure Healing With SclerosTin Antibody - Hip Phase 2
Recruiting NCT03871322 - The Vitamin K2 and D3 Intervention Trial in Children and Adolescents With the Low-energy Fractures N/A
Terminated NCT00435877 - Procurement of Tissue Samples for Cell Cultures and Analyses
Completed NCT04783337 - Local Remodelling of Bone Fracture Healing N/A